Heme/Onc Pharm Flashcards
Can be used to prevent mast cell degranulation
Cromolyn sodium Pharmacology Heme/Onc
Treatment of lead poisoning
Dimercaprol and EDTA, succimer in kids Pharmacology Heme/Onc
Heparin (mechanism, use, toxicity)
Activates antithrombin, which inactivates thrombin and Xa; used for immediate coagulation and in pregnant women; some patients develop antibodies to platelet factor 4 (HIT) Pharmacology Heme/Onc
Enoxaparin, dalteparin (mechanism, use, toxicity)
Same actions as heparin, but has a longer half-life, does not have to be monitored as closely, and has a reduced risk of HIT Pharmacology Heme/Onc
Warfarin (mechanism, use, toxicity)
Inactivated gamma-carboxylation of factors II, VII, IX, X, C, and S; used for long-term and non-immediate anticoagulation; can cause tissue necrosis, teratogenic Pharmacology Heme/Onc
Alteplase, reteplase, tenecteplase (mechanism, use, toxicity)
Converts plasminogen to plasmin; used as a thrombolytic Pharmacology Heme/Onc
Aspirin (mechanism, use, toxicity)
Irreversibly inhibits COX-1 and COX-2; anti-platelet and anti-inflammatory; gastric ulcers, tinnitus, Reye’s syndrome in childhood viral infections Pharmacology Heme/Onc
Clopidogrel, ticlodipine, prasugrel, ticagrelor (mechanism, use, toxicity)
Irreversibly blocks ADP receptors on platelets, preventing degranulation; used for acure coronary syndrome; ticlodipine causes neutropenia Pharmacology Heme/Onc
Cilostazol, dipyridamole (mechanism, use, toxicity)
Phosphodiesterase inhibitor, increases cAMP and decreases ADP, preventing platelet degranulation; nausea, headache, facial flushing, hypotension Pharmacology Heme/Onc
Abciximab, eptifibatide, tirofiban (mechanism, use, toxicity)
GPIIb/IIIa inhibitors, preventing platelet aggregation; bleeding, thrombocytopenia Pharmacology Heme/Onc
Methotrexate (mechanism, use, toxicity)
Inhibits dihydrofolate reductase, inhibiting DNA synthesis; myelosuppression, macrovesicular fatty change in liver Pharmacology Heme/Onc
5-fluorouracil (mechanism, use, toxicity)
Pyrimidine analog that is activated and inhibits thymidylate synthase, inhibiting DNA synthesis; myelosuppression, photosensitivity Pharmacology Heme/Onc
Cytarabine (mechanism, use, toxicity)
Pyrimidine analog that inhibits DNA polymerase; leukopenia, thrombocytopenia, megaloblastic anemia Pharmacology Heme/Onc
Azathioprine, 6-mercaptopurine, 6-thioguanine (mechanism, use, toxicity)
Purine analogs that are activated by HGPRT and inhibit purine synthesis; toxicity is increased with allopurinol, causes bone marrow, GI, and liver toxicity Pharmacology Heme/Onc
Dactinomycin (actinomycin D) (mechanism, use, toxicity)
DNA intercalator; used for childhood tumors; myelosuppression Pharmacology Heme/Onc